Interleuchina 23 (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Interleuchina 23" in Italian language version.

refsWebsite

Global rank Italian rank

3sciencedirect.com

149^th place

298^th place

234^th place

226^th place

1atsjournals.org

low place

low place

222^nd place

243^rd place

low place

low place

low place

6,584^th place

2,769^th place

2,222^nd place

2,374^th place

1,283^rd place

atsjournals.org (Global: low place; Italian: low place)

(EN) Wakashin H, Hirose K, Maezawa Y et al., IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice, in American Journal of Respiratory and Critical Care Medicine, n. 178, 2008, pp. 1023-1032.

jimmunol.org (Global: low place; Italian: low place)

(EN) Tonel G, Conrad C, Laggner U et al., Cutting edge: a critical functional role for IL-23 in psoriasis, in Journal of Immunology, n. 185, 2010, pp. 5688-5691.

lww.com (Global: 2,769^th place; Italian: 2,222^nd place)

journals.lww.com

(EN) Eken A, Singh AK, Oukka M, Interleukin 23 in Crohn's disease, in Inflamm Bowel Dis, vol. 20, 2014, pp. 587-595.

nature.com (Global: 234^th place; Italian: 226^th place)

(EN) Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD, Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation, in Nat Immunol, vol. 9, 2008, pp. 873-879.
(EN) Volpe E, Servant N, Zollinger R et al., A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses, in Nat Immunol, vol. 9, 2008, pp. 650-657.

nejm.org (Global: 2,374^th place; Italian: 1,283^rd place)

(EN) Brightling CE, Nair P, Cousins DJ, Louis R, Singh D, Risankizumab in severe asthma — a phase 2a, placebo-controlled trial, in New England Journal of Medicine, n. 385, 2021, pp. 1669-1679.

rupress.org (Global: low place; Italian: 6,584^th place)

jem.rupress.org

(EN) Langrish CL, Chen Y, Blumenschein WM et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, in J Exp Med, n. 201, 2005, pp. 233-240.

sciencedirect.com (Global: 149^th place; Italian: 298^th place)

(EN) Oppmann B, Lesley R, Blom B et al., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, in Immunity, vol. 13, 2000, pp. 715-725.
(EN) Gordon KB, Strober B, Lebwohl M et al., Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials, in Lancet, n. 392, 2018, pp. 650-661.
(EN) Feagan BG, Sandborn WJ, D’Haens G et al., Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn’s disease: a randomised, double-blind, placebo-controlled phase 2 study, in Lancet, n. 389, 2017, pp. 1699-1709.

wiley.com (Global: 222^nd place; Italian: 243^rd place)

onlinelibrary.wiley.com

(EN) Li Y, Hua S, Mechanisms of pathogenesis in allergic asthma: role of interleukin-23, in Respirology, vol. 19, 2014, pp. 663-669.